The elusive goal of liver support - Quest for the Holy Grail

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 6, Issue 5, 2006, Pages 482-487

  Williams, Roger ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Albumin dialysis; Bioartificial devices; Charcoal haemoperfusion; Liver failure; Water soluble protein bound toxins

Indexed keywords

CHARCOAL;

ALBUMIN DIALYSIS; BIOARTIFICIAL LIVER; BIOREACTOR; CELL CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL; LIVER SUPPORT; LIVER TRANSPLANTATION; SURVIVAL;

EID: 33750606682     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.6-5-482     Document Type: Conference Paper

References (32)

1. Hughes RD, Cochrane AM, Thomson AD, Murray-Lyon IM, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 1976;57:348-53.
2. Sambit Sen, Williams R. New liver support devices in acute liver failure: a critical evaluation. Semin Liver Dis 2003;23:283-94.
3. Kiley JE, Gundermann KJ, Lie TS. Ammonia intoxication treated by hemodialysis. N Engl J Med 1958;25:1156-61.
4. Opolon P, Rapin JR, Huguet C et al. Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs 1976;22:701-10.
5. Lee C, Tink A. Exchange transfusion in hepatic coma: report of a case. Med J Aust 1958;45:40-2.
6. Trey MB, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966;274:473-81.
7. Larsen FS, Hansen BA, Ejlersen E et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 1996;8:261-5.
8. Pascher A, Sauer IM, Neuhaus P. Analysis of allogeneic versus xenogeneic auxiliary organ perfusion in liver failure reveals superior efficacy of human livers. Int J Artif Organs 2002;25:1006-12.
9. 8a Abouna GM, Boehmig HG, Serrou B, Amemiya H, Martineau G. Long-term hepatic support by intermittent multi-species liver perfusions. Lancet 1970;2:391-6.
10. Burnell JM, Dawborn JK, Epstein RB et al. Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 1967;276:935-43.
11. Chang TMS. Hemoperfusions over a microencapsulated adsorbent in a patient with hepatic coma. Lancet 1972;2:1371-2.
12. Gazzard BG, Langley PG, Weston MJ, Dunlop EH, Williams R. Polymer coating of activated charcoal and its effects on biocompatibility and paracetamol binding. Clin Sci Mol Med 1974;47:97-104.
13. Gimson AE, Hughes RD, Mellon PJ et al. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet 1980;1:173-5.
14. Gazzard BG, Weston MJ, Murray-Lyon IM et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974;1:1301-7.
15. Gimson AE, Mellon PJ, Braude S, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982;2:681-3.
16. O'Grady JG, Gimson AE, O'Brien CJ et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-92.
17. Horak J, Horky J, Rabl M. Haemoperfusion through activated charcoal in dogs with fulminant liver failure. Digestion 1980;20:22-30.
18. Toledo-Pereyra LH. Utilization of activated carbon hemoperfusion to assist recovery of ischemically damaged canine liver allografts. Artif Organs 1985;9:243-9.
19. Hughes R, Ton HY, Langley P et al. Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part II: in vivo evaluation. Artif Organs 1979;3:23-6.
20. Ellis AJ, Sussman NL, Kelly JH, Williams R. Clinical experience with an extracorporeal liver assist device. In: Lee WM, Williams R, (eds), Acute liver failure. Cambridge: Cambridge University Press, 1997:255-65.
21. Millis JM, Kramer DJ, O'Grady J et al. Results of phase I trial of the extracorporeal liver assist device for patient with fulminant hepatic failure. Am J Transplantation 2001;1(Suppl 1):391.
22. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000;32(1 Suppl):63-76.
23. Demetriou AA, Brown RS Jr, Busuttil RW et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-7.
24. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993;17:809-13.
25. Heemann U, Treichel U, Loock J et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58.
26. Hassanein T, Brown RS Jr, McGuire BM et al. Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: a prospective, controlled randomized multicenter trial. Hepatology 2004;40(Supp 1):726A.
27. Stange J, Hassanein TI, Mehta R et al. Short-term survival of patients with severe intractable hepatic encephalopathy: The role of albumin dialysis. Hepatology 2005;42(Supp 1):286A.
28. Jalan R, Sen S, Steiner C et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003;38:24-31.
29. Sorkine P, Ben Abraham R, Szold O et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001;29:1332-6.
30. Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 2001;7:709-12.
31. Rifai K, Ernst T, Kretschmer U et al. Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-90.
32. Krisper P, Haditsch B, Stauber R et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005;43:451-7.